BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wei W, Chua MS, Grepper S, So SK. Blockade of Wnt-1 signaling leads to anti-tumor effects in hepatocellular carcinoma cells. Mol Cancer 2009;8:76. [PMID: 19778454 DOI: 10.1186/1476-4598-8-76] [Cited by in Crossref: 63] [Cited by in F6Publishing: 60] [Article Influence: 4.8] [Reference Citation Analysis]
Number Citing Articles
1 Zarei N, Fazeli M, Mohammadi M, Nejatollahi F. Cell growth inhibition and apoptosis in breast cancer cells induced by anti-FZD7 scFvs: involvement of bioinformatics-based design of novel epitopes. Breast Cancer Res Treat 2018;169:427-36. [DOI: 10.1007/s10549-017-4641-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
2 Liu D, Liu Y, Liu M, Ran L, Li Y. Reversing resistance of multidrug-resistant hepatic carcinoma cells with parthenolide. Future Oncology 2013;9:595-604. [DOI: 10.2217/fon.13.15] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
3 Han YF, Zhao J, Ma LY, Yin JH, Chang WJ, Zhang HW, Cao GW. Factors predicting occurrence and prognosis of hepatitis-B-virus-related hepatocellular carcinoma. World J Gastroenterol. 2011;17:4258-4270. [PMID: 22090781 DOI: 10.3748/wjg.v17.i38.4258.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Li YY, Fan YJ, Zou H, Jiang HT, Li JX, Sun LJ, Cao JY. Docosahexaenoic acid promotes apoptosis and inhibits proliferation of HepG2 cells by altering β-catenin and C-myc expression. Shijie Huaren Xiaohua Zazhi 2014; 22(13): 1834-1840 [DOI: 10.11569/wcjd.v22.i13.1834] [Reference Citation Analysis]
5 Novellasdemunt L, Antas P, Li VS. Targeting Wnt signaling in colorectal cancer. A Review in the Theme: Cell Signaling: Proteins, Pathways and Mechanisms. Am J Physiol Cell Physiol. 2015;309:C511-C521. [PMID: 26289750 DOI: 10.1152/ajpcell.00117.2015] [Cited by in Crossref: 182] [Cited by in F6Publishing: 172] [Article Influence: 26.0] [Reference Citation Analysis]
6 Azam M, Hussain Z, Warad I, Al-resayes SI, Khan MS, Shakir M, Trzesowska-kruszynska A, Kruszynski R. Novel Pd(ii)–salen complexes showing high in vitro anti-proliferative effects against human hepatoma cancer by modulating specific regulatory genes. Dalton Trans 2012;41:10854. [DOI: 10.1039/c2dt31143g] [Cited by in Crossref: 38] [Cited by in F6Publishing: 27] [Article Influence: 3.8] [Reference Citation Analysis]
7 Morgan TR. Chemoprevention of hepatocellular carcinoma in chronic hepatitis C. Recent Results Cancer Res. 2011;188:85-99. [PMID: 21253791 DOI: 10.1007/978-3-642-10858-7_7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
8 Su W, Meng F, Huang L, Zheng M, Liu W, Sun H. Sonic hedgehog maintains survival and growth of chronic myeloid leukemia progenitor cells through β-catenin signaling. Exp Hematol 2012;40:418-27. [PMID: 22240607 DOI: 10.1016/j.exphem.2012.01.003] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 2.1] [Reference Citation Analysis]
9 Choi A, Park J, Kim R, Kim S, Cho S, Jung J, Nam J. Inhibition of Wnt1 expression reduces the enrichment of cancer stem cells in a mouse model of breast cancer. Biochemical and Biophysical Research Communications 2012;425:436-42. [DOI: 10.1016/j.bbrc.2012.07.120] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
10 Dahmani R, Just PA, Perret C. The Wnt/β-catenin pathway as a therapeutic target in human hepatocellular carcinoma. Clin Res Hepatol Gastroenterol. 2011;35:709-713. [PMID: 21778132 DOI: 10.1016/j.clinre.2011.05.010] [Cited by in Crossref: 58] [Cited by in F6Publishing: 59] [Article Influence: 5.3] [Reference Citation Analysis]
11 Singla A, Wang J, Yang R, Geller DS, Loeb DM, Hoang BH. Wnt Signaling in Osteosarcoma. Adv Exp Med Biol 2020;1258:125-39. [PMID: 32767238 DOI: 10.1007/978-3-030-43085-6_8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
12 Azbazdar Y, Karabicici M, Erdal E, Ozhan G. Regulation of Wnt Signaling Pathways at the Plasma Membrane and Their Misregulation in Cancer. Front Cell Dev Biol 2021;9:631623. [PMID: 33585487 DOI: 10.3389/fcell.2021.631623] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
13 Chen SR, Qiu HC, Hu Y, Wang Y, Wang YT. Herbal Medicine Offered as an Initiative Therapeutic Option for the Management of Hepatocellular Carcinoma. Phytother Res 2016;30:863-77. [PMID: 26879574 DOI: 10.1002/ptr.5594] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
14 Liu J, Ding X, Tang J, Cao Y, Hu P, Zhou F, Shan X, Cai X, Chen Q, Ling N. Enhancement of canonical Wnt/β-catenin signaling activity by HCV core protein promotes cell growth of hepatocellular carcinoma cells. PLoS One. 2011;6:e27496. [PMID: 22110662 DOI: 10.1371/journal.pone.0027496] [Cited by in Crossref: 80] [Cited by in F6Publishing: 76] [Article Influence: 7.3] [Reference Citation Analysis]
15 Pez F, Lopez A, Kim M, Wands JR, Caron de Fromentel C, Merle P. Wnt signaling and hepatocarcinogenesis: molecular targets for the development of innovative anticancer drugs. J Hepatol 2013;59:1107-17. [PMID: 23835194 DOI: 10.1016/j.jhep.2013.07.001] [Cited by in Crossref: 172] [Cited by in F6Publishing: 161] [Article Influence: 19.1] [Reference Citation Analysis]
16 Zhou A, Tang L, Zeng S, Lei Y, Yang S, Tang B. Gut microbiota: A new piece in understanding hepatocarcinogenesis. Cancer Lett 2020;474:15-22. [PMID: 31917160 DOI: 10.1016/j.canlet.2020.01.002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
17 Ma L, Wang X, Jia T, Wei W, Chua MS, So S. Tankyrase inhibitors attenuate WNT/β-catenin signaling and inhibit growth of hepatocellular carcinoma cells. Oncotarget. 2015;6:25390-25401. [PMID: 26246473 DOI: 10.18632/oncotarget.4455] [Cited by in Crossref: 51] [Cited by in F6Publishing: 57] [Article Influence: 8.5] [Reference Citation Analysis]
18 Chiang H, Liao AT, Jan T, Wang Y, Lei H, Tsai M, Chen M, Lee C, Lin Y, Chu R, Lin C. Gene-expression profiling to identify genes related to spontaneous tumor regression in a canine cancer model. Veterinary Immunology and Immunopathology 2013;151:207-16. [DOI: 10.1016/j.vetimm.2012.11.009] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
19 Wang JM, Huang FC, Kuo MH, Wang ZF, Tseng TY, Chang LC, Yen SJ, Chang TC, Lin JJ. Inhibition of cancer cell migration and invasion through suppressing the Wnt1-mediating signal pathway by G-quadruplex structure stabilizers. J Biol Chem 2014;289:14612-23. [PMID: 24713700 DOI: 10.1074/jbc.M114.548230] [Cited by in Crossref: 27] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
20 White BD, Chien AJ, Dawson DW. Dysregulation of Wnt/β-catenin signaling in gastrointestinal cancers. Gastroenterology 2012;142:219-32. [PMID: 22155636 DOI: 10.1053/j.gastro.2011.12.001] [Cited by in Crossref: 309] [Cited by in F6Publishing: 295] [Article Influence: 28.1] [Reference Citation Analysis]
21 Haymerle G, Schneider S, Harris L, Häupl T, Schopper C, Pammer J, Grasl MC, Erovic BM. Minor salivary gland carcinoma: a review of 35 cases. Eur Arch Otorhinolaryngol 2016;273:2717-26. [DOI: 10.1007/s00405-015-3805-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
22 Pistocchi A, Fazio G, Cereda A, Ferrari L, Bettini LR, Messina G, Cotelli F, Biondi A, Selicorni A, Massa V. Cornelia de Lange Syndrome: NIPBL haploinsufficiency downregulates canonical Wnt pathway in zebrafish embryos and patients fibroblasts. Cell Death Dis 2013;4:e866. [PMID: 24136230 DOI: 10.1038/cddis.2013.371] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 4.3] [Reference Citation Analysis]
23 Patel P, Schutzer SE, Pyrsopoulos N. Immunobiology of hepatocarcinogenesis: Ways to go or almost there? World J Gastrointest Pathophysiol 2016; 7(3): 242-255 [PMID: 27574562 DOI: 10.4291/wjgp.v7.i3.242] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
24 Zimmerman ZF, Moon RT, Chien AJ. Targeting Wnt pathways in disease. Cold Spring Harb Perspect Biol 2012;4:a008086. [PMID: 23001988 DOI: 10.1101/cshperspect.a008086] [Cited by in Crossref: 67] [Cited by in F6Publishing: 63] [Article Influence: 6.7] [Reference Citation Analysis]
25 Thomson JP, Hunter JM, Lempiäinen H, Müller A, Terranova R, Moggs JG, Meehan RR. Dynamic changes in 5-hydroxymethylation signatures underpin early and late events in drug exposed liver. Nucleic Acids Res 2013;41:5639-54. [PMID: 23598998 DOI: 10.1093/nar/gkt232] [Cited by in Crossref: 67] [Cited by in F6Publishing: 61] [Article Influence: 7.4] [Reference Citation Analysis]
26 Wang W, Smits R, Hao H, He C. Wnt/β-Catenin Signaling in Liver Cancers. Cancers (Basel) 2019;11:E926. [PMID: 31269694 DOI: 10.3390/cancers11070926] [Cited by in Crossref: 32] [Cited by in F6Publishing: 38] [Article Influence: 10.7] [Reference Citation Analysis]
27 Papagerakis S, Pannone G, Zheng L, About I, Taqi N, Nguyen NP, Matossian M, McAlpin B, Santoro A, McHugh J, Prince ME, Papagerakis P. Oral epithelial stem cells - implications in normal development and cancer metastasis. Exp Cell Res 2014;325:111-29. [PMID: 24803391 DOI: 10.1016/j.yexcr.2014.04.021] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 3.1] [Reference Citation Analysis]
28 Ahsani Z, Mohammadi-Yeganeh S, Kia V, Karimkhanloo H, Zarghami N, Paryan M. WNT1 Gene from WNT Signaling Pathway Is a Direct Target of miR-122 in Hepatocellular Carcinoma. Appl Biochem Biotechnol. 2017;181:884-897. [PMID: 27687586 DOI: 10.1007/s12010-016-2256-8] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 5.0] [Reference Citation Analysis]
29 Caspi M, Wittenstein A, Kazelnik M, Shor-Nareznoy Y, Rosin-Arbesfeld R. Therapeutic targeting of the oncogenic Wnt signaling pathway for treating colorectal cancer and other colonic disorders. Adv Drug Deliv Rev 2021;169:118-36. [PMID: 33346022 DOI: 10.1016/j.addr.2020.12.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
30 Gao H, Yin FF, Guan DX, Feng YX, Zheng QW, Wang X, Zhu M, Zhang XL, Cheng SQ, Chen TW, Jiang H, Zhang EB, Wang JJ, Ni QZ, Yuan YM, Zhang FK, Ma N, Cao HJ, Wang YK, Li JJ, Xie D. Liver cancer: WISP3 suppresses hepatocellular carcinoma progression by negative regulation of β-catenin/TCF/LEF signalling. Cell Prolif 2019;52:e12583. [PMID: 30793395 DOI: 10.1111/cpr.12583] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
31 Swoboda J, Mittelsdorf P, Chen Y, Weiskirchen R, Stallhofer J, Schüle S, Gassler N. Intestinal Wnt in the transition from physiology to oncology. World J Clin Oncol 2022; 13(3): 168-185 [DOI: 10.5306/wjco.v13.i3.168] [Reference Citation Analysis]
32 Zha TZ, Hu BS, Yu HF, Tan YF, Zhang Y, Zhang K. Overexpression of HOXA1 correlates with poor prognosis in patients with hepatocellular carcinoma. Tumour Biol 2012;33:2125-34. [PMID: 22864671 DOI: 10.1007/s13277-012-0472-6] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 2.7] [Reference Citation Analysis]
33 Degirmenci B, Hausmann G, Valenta T, Basler K. Wnt Ligands as a Part of the Stem Cell Niche in the Intestine and the Liver. WNT Signaling in Health and Disease. Elsevier; 2018. pp. 1-19. [DOI: 10.1016/bs.pmbts.2017.11.011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
34 Lin CH, Ji T, Chen CF, Hoang BH. Wnt signaling in osteosarcoma. Adv Exp Med Biol 2014;804:33-45. [PMID: 24924167 DOI: 10.1007/978-3-319-04843-7_2] [Cited by in Crossref: 52] [Cited by in F6Publishing: 45] [Article Influence: 6.5] [Reference Citation Analysis]
35 Miao CL, Li CM, Zhou DH. Wnt signaling pathway and hepatic carcinogenesis. Shijie Huaren Xiaohua Zazhi 2014; 22(21): 3056-3060 [DOI: 10.11569/wcjd.v22.i21.3056] [Reference Citation Analysis]
36 Roy JP, Halford MM, Stacker SA. The biochemistry, signalling and disease relevance of RYK and other WNT-binding receptor tyrosine kinases. Growth Factors 2018;36:15-40. [PMID: 29806777 DOI: 10.1080/08977194.2018.1472089] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 4.8] [Reference Citation Analysis]
37 Podolski-renić A, Milošević Z, Dinić J, Stanković T, Banković J, Pešić M. Mutual regulation and targeting of multidrug resistance and cancer stem phenotype. Med Chem Commun 2016;7:2265-81. [DOI: 10.1039/c6md00391e] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
38 Kong N, Kuang ZP, Yang F, Li YQ, Wu JN. Significance of expression of Wnt-1 in chemically induced liver carcinogenesis in mice. Shijie Huaren Xiaohua Zazhi 2014; 22(6): 751-758 [DOI: 10.11569/wcjd.v22.i6.751] [Reference Citation Analysis]
39 Dellinger TH, Planutis K, Tewari KS, Holcombe RF. Role of canonical Wnt signaling in endometrial carcinogenesis. Expert Rev Anticancer Ther 2012;12:51-62. [PMID: 22149432 DOI: 10.1586/era.11.194] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 3.2] [Reference Citation Analysis]
40 Yang K, Wang X, Zhang H, Wang Z, Nan G, Li Y, Zhang F, Mohammed MK, Haydon RC, Luu HH, Bi Y, He TC. The evolving roles of canonical WNT signaling in stem cells and tumorigenesis: implications in targeted cancer therapies. Lab Invest 2016;96:116-36. [PMID: 26618721 DOI: 10.1038/labinvest.2015.144] [Cited by in Crossref: 104] [Cited by in F6Publishing: 111] [Article Influence: 14.9] [Reference Citation Analysis]
41 Li Y, Wang Z, Ajani JA, Song S. Drug resistance and Cancer stem cells. Cell Commun Signal 2021;19:19. [PMID: 33588867 DOI: 10.1186/s12964-020-00627-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
42 Ampuero J, Romero-Gomez M. Prevention of hepatocellular carcinoma by correction of metabolic abnormalities: Role of statins and metformin. World J Hepatol 2015; 7(8): 1105-1111 [PMID: 26052399 DOI: 10.4254/wjh.v7.i8.1105] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
43 Han YF, Zhao J, Ma LY, Yin JH, Chang WJ, Zhang HW, Cao GW. Factors predicting occurrence and prognosis of hepatitis-B-virus-related hepatocellular carcinoma. World J Gastroenterol 2011; 17(38): 4258-4270 [PMID: 22090781 DOI: 10.3748/wjg.v17.i38.4258] [Cited by in CrossRef: 52] [Cited by in F6Publishing: 54] [Article Influence: 4.7] [Reference Citation Analysis]
44 Rangwala F, Omenetti A, Diehl AM. Cancer stem cells: repair gone awry? J Oncol. 2011;2011:465343. [PMID: 21188169 DOI: 10.1155/2011/465343] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
45 Chen L, Wang X, Zhu Y, Zhu J, Lai Q. miR‑200b‑3p inhibits proliferation and induces apoptosis in colorectal cancer by targeting Wnt1. Mol Med Rep 2018;18:2571-80. [PMID: 30015876 DOI: 10.3892/mmr.2018.9287] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
46 Dong JJ, Ying L, Shi KQ. Expression of the Wnt ligands gene family and its relationship to prognosis in hepatocellular carcinoma. Cancer Cell Int 2019;19:34. [PMID: 30814912 DOI: 10.1186/s12935-019-0743-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
47 Yao H, Ashihara E, Maekawa T. Targeting the Wnt/β-catenin signaling pathway in human cancers. Expert Opin Ther Targets. 2011;15:873-887. [PMID: 21486121 DOI: 10.1517/14728222.2011.577418] [Cited by in Crossref: 115] [Cited by in F6Publishing: 108] [Article Influence: 10.5] [Reference Citation Analysis]
48 Shi H, Huttad LV, Tan M, Liu H, Chua M, Cheng Z, So S. NIR-II imaging of hepatocellular carcinoma based on a humanized anti-GPC3 antibody. RSC Med Chem 2022;13:90-7. [DOI: 10.1039/d1md00313e] [Reference Citation Analysis]
49 O’flaherty JD, Barr M, Fennell D, Richard D, Reynolds J, O’leary J, O’byrne K. The Cancer Stem-Cell Hypothesis: Its Emerging Role in Lung Cancer Biology and Its Relevance for Future Therapy. Journal of Thoracic Oncology 2012;7:1880-90. [DOI: 10.1097/jto.0b013e31826bfbc6] [Cited by in Crossref: 82] [Cited by in F6Publishing: 42] [Article Influence: 8.2] [Reference Citation Analysis]
50 Huldani H, Jasim SA, Sergeenva KN, Bokov DO, Abdelbasset WK, Turakulov R, Al-Gazally ME, Ahmadzadeh B, Jawhar ZH, Siahmansouri H. Mechanisms of cancer stem cells drug resistance and the pivotal role of HMGA2. Pathol Res Pract 2022;234:153906. [PMID: 35468338 DOI: 10.1016/j.prp.2022.153906] [Reference Citation Analysis]
51 Delgado E, Bahal R, Yang J, Lee JM, Ly DH, Monga SP. β-Catenin knockdown in liver tumor cells by a cell permeable gamma guanidine-based peptide nucleic acid. Curr Cancer Drug Targets. 2013;13:867-878. [PMID: 23822752 DOI: 10.2174/15680096113139990081] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
52 Yang Y, Li H, Hou S, Hu B, Liu J, Wang J. The noncoding RNA expression profile and the effect of lncRNA AK126698 on cisplatin resistance in non-small-cell lung cancer cell. PLoS One. 2013;8:e65309. [PMID: 23741487 DOI: 10.1371/journal.pone.0065309] [Cited by in Crossref: 170] [Cited by in F6Publishing: 179] [Article Influence: 18.9] [Reference Citation Analysis]
53 Chang LC, Chen TC, Chen SJ, Chen CL, Lee CC, Wu SH, Yen Y, Huang HS, Lin JJ. Identification of a new class of WNT1 inhibitor: Cancer cells migration, G-quadruplex stabilization and target validation. Oncotarget 2016;7:67986-8001. [PMID: 27626678 DOI: 10.18632/oncotarget.6622] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
54 Lii CK, Chang JW, Chen JJ, Chen HW, Liu KL, Yeh SL, Wang TS, Liu SH, Tsai CH, Li CC. Docosahexaenoic acid inhibits 12-O-tetradecanoylphorbol-13- acetate-induced fascin-1-dependent breast cancer cell migration by suppressing the PKCδ- and Wnt-1/β-catenin-mediated pathways. Oncotarget 2016;7:25162-79. [PMID: 27036017 DOI: 10.18632/oncotarget.7301] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 7.0] [Reference Citation Analysis]
55 Dong L, Duan XC, Han CX, Zhang H, Wu Y. Suppression of wingless-type MMTV integration site family, member 1 expression by small interfering RNA inhibits U251 glioma cell growth in vitro.. Oncol Lett 2015;9:81-5. [PMID: 25435937 DOI: 10.3892/ol.2014.2647] [Reference Citation Analysis]
56 Fazio G, Gaston-Massuet C, Bettini LR, Graziola F, Scagliotti V, Cereda A, Ferrari L, Mazzola M, Cazzaniga G, Giordano A, Cotelli F, Bellipanni G, Biondi A, Selicorni A, Pistocchi A, Massa V. CyclinD1 Down-Regulation and Increased Apoptosis Are Common Features of Cohesinopathies. J Cell Physiol 2016;231:613-22. [PMID: 26206533 DOI: 10.1002/jcp.25106] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
57 Abdel aziz MT, El Asmar MF, Atta HM, Mahfouz S, Fouad HH, Roshdy NK, Rashed LA, Sabry D, Hassouna AA, Taha FM. Efficacy of mesenchymal stem cells in suppression of hepatocarcinorigenesis in rats: possible role of Wnt signaling. J Exp Clin Cancer Res 2011;30:49. [PMID: 21545718 DOI: 10.1186/1756-9966-30-49] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 4.1] [Reference Citation Analysis]
58 Ozcan M, Altay O, Lam S, Turkez H, Aksoy Y, Nielsen J, Uhlen M, Boren J, Mardinoglu A. Improvement in the Current Therapies for Hepatocellular Carcinoma Using a Systems Medicine Approach. Adv Biosyst 2020;4:e2000030. [PMID: 32529800 DOI: 10.1002/adbi.202000030] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
59 Lu JT, Zhao WD, He W, Wei W. Hedgehog signaling pathway mediates invasion and metastasis of hepatocellular carcinoma via ERK pathway. Acta Pharmacol Sin. 2012;33:691-700. [PMID: 22543708 DOI: 10.1038/aps.2012.24] [Cited by in Crossref: 54] [Cited by in F6Publishing: 48] [Article Influence: 5.4] [Reference Citation Analysis]
60 Gao W, Kim H, Feng M, Phung Y, Xavier CP, Rubin JS, Ho M. Inactivation of Wnt signaling by a human antibody that recognizes the heparan sulfate chains of glypican-3 for liver cancer therapy. Hepatology. 2014;60:576-587. [PMID: 24492943 DOI: 10.1002/hep.26996] [Cited by in Crossref: 94] [Cited by in F6Publishing: 92] [Article Influence: 11.8] [Reference Citation Analysis]
61 Sklavos A, Poutahidis T, Giakoustidis A, Makedou K, Angelopoulou K, Hardas A, Andreani P, Zacharioudaki A, Saridis G, Goulopoulos T, Tsarea K, Karamperi M, Papadopoulos V, Papanikolaou V, Papalois A, Iliadis S, Mudan S, Azoulay D, Giakoustidis D. Effects of Wnt-1 blockade in DEN-induced hepatocellular adenomas of mice. Oncol Lett 2018;15:1211-9. [PMID: 29399175 DOI: 10.3892/ol.2017.7427] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
62 Zhou Y, Zhou N, Fang W, Huo J. Overexpressed HDGF as an independent prognostic factor is involved in poor prognosis in Chinese patients with liver cancer. Diagn Pathol 2010;5:58. [PMID: 20846397 DOI: 10.1186/1746-1596-5-58] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
63 de Jesus Perez V, Yuan K, Alastalo TP, Spiekerkoetter E, Rabinovitch M. Targeting the Wnt signaling pathways in pulmonary arterial hypertension. Drug Discov Today 2014;19:1270-6. [PMID: 24955837 DOI: 10.1016/j.drudis.2014.06.014] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
64 Zhang J, Huang K, Shi Z, Zou J, Wang Y, Jia Z, Zhang A, Han L, Yue X, Liu N, Jiang T, You Y, Pu P, Kang C. High β-catenin/Tcf-4 activity confers glioma progression via direct regulation of AKT2 gene expression. Neuro Oncol 2011;13:600-9. [PMID: 21636708 DOI: 10.1093/neuonc/nor034] [Cited by in Crossref: 53] [Cited by in F6Publishing: 50] [Article Influence: 4.8] [Reference Citation Analysis]